Literature DB >> 30461121

MARSHALL bundles elimination, Pulmonary veins isolation and Lines completion for ANatomical ablation of persistent atrial fibrillation: MARSHALL-PLAN case series.

Thomas Pambrun1, Arnaud Denis1, Josselin Duchateau1, Frédéric Sacher1, Mélèze Hocini1, Pierre Jaïs1, Michel Haïssaguerre1, Nicolas Derval1.   

Abstract

INTRODUCTION: Beyond pulmonary veins (PV) isolation, the ablation strategy for persistent atrial fibrillation (AF) remains controversial. Substrate ablation may provide a high termination rate but at the cost of impaired atrial physiology and recurrent complex re-entries. To overcome these pitfalls, we investigated a new lesion set based on important anatomical considerations. METHODS AND
RESULTS: The case series included 10 consecutive patients with persistent AF. Three atrial structures were successively targeted: (1) coronary sinus and vein of Marshall (CS-VOM) musculature elimination; (2) PVs isolation; and (3) anatomical isthmuses block. The lesion set completion was the procedural endpoint. Step 1: VOM ethanol infusion was feasible in all cases (mean time of 33.4 ± 9.4 minutes), mean radiofrequency (RF) time for CS-VOM bundles was 14.4 ± 6.9 minutes. Step 2: mean RF time for PV isolation was 27.7 ± 9.3 minutes. Step 3: mean RF time for mitral, roof, and cavotricuspid lines was 5.7 ± 2.3, 8.1 ± 4.3, and 5.9 ± 1.9 minutes, respectively. The lesion set was achieved in all patients. Mean procedure time was 270 ± 29.9 minutes. AF termination and noninducibility were, respectively, obtained in 50% and 90% of the patients. After a 6-month follow-up, all patients were free from arrhythmia recurrence.
CONCLUSION: The present case series reports a new ablation strategy systematically targeting anatomical structures previously identified as possibly involved in the fibrillatory process and the recurrent tachycardias. The resulting lesion set provides good short-term outcomes. Although promising, these preliminary results need to be confirmed in the larger prospective study.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  alcohol injection; atrial fibrillation; catheter ablation; coronary sinus ablation; vein of Marshall

Mesh:

Substances:

Year:  2018        PMID: 30461121     DOI: 10.1111/jce.13797

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

1.  Ten Steps in Adoption of Emerging Procedural Techniques: An Experience With Ethanol Ablation of Vein of Marshall (VOM).

Authors:  Talha Wahid; Hafiza Khan; Mustafa M Dohadwala
Journal:  Cureus       Date:  2022-05-12

2.  Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial.

Authors:  Miguel Valderrábano; Leif E Peterson; Vijay Swarup; Paul A Schurmann; Akash Makkar; Rahul N Doshi; David DeLurgio; Charles A Athill; Kenneth A Ellenbogen; Andrea Natale; Jayanthi Koneru; Amish S Dave; Irakli Giorgberidze; Hamid Afshar; Michelle L Guthrie; Raquel Bunge; Carlos A Morillo; Neal S Kleiman
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

Review 3.  Vein of Marshall ethanol infusion in the treatment of atrial fibrillation: From concept to clinical practice.

Authors:  Miguel Valderrábano
Journal:  Heart Rhythm       Date:  2021-03-26       Impact factor: 6.779

Review 4.  Challenges Associated with Interpreting Mechanisms of AF.

Authors:  Caroline H Roney; Andrew L Wit; Nicholas S Peters
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-02-12

Review 5.  The Long-Term Outcomes of Ablation With Vein of Marshall Ethanol Infusion vs. Ablation Alone in Patients With Atrial Fibrillation: A Meta-Analysis.

Authors:  Feng Li; Jin-Yu Sun; Li-Da Wu; Lei Zhang; Qiang Qu; Chao Wang; Ling-Ling Qian; Ru-Xing Wang
Journal:  Front Cardiovasc Med       Date:  2022-04-29

Review 6.  Ethanol Infusion of Vein of Marshall for the Treatment of Persistent Atrial Fibrillation: The Basics and Clinical Practice.

Authors:  Bo He; Fang Zhao; Wenxi Yu; Yi Li; Xiaoyan Wu; Zhibing Lu
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-16

7.  RADAR: A Multicenter Food and Drug Administration Investigational Device Exemption Clinical Trial of Persistent Atrial Fibrillation.

Authors:  Subbarao Choudry; Moussa Mansour; Sri Sundaram; Duy T Nguyen; Srinivas R Dukkipati; William Whang; Paul Kessman; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-01-16

8.  In silico Comparison of Left Atrial Ablation Techniques That Target the Anatomical, Structural, and Electrical Substrates of Atrial Fibrillation.

Authors:  Caroline H Roney; Marianne L Beach; Arihant M Mehta; Iain Sim; Cesare Corrado; Rokas Bendikas; Jose A Solis-Lemus; Orod Razeghi; John Whitaker; Louisa O'Neill; Gernot Plank; Edward Vigmond; Steven E Williams; Mark D O'Neill; Steven A Niederer
Journal:  Front Physiol       Date:  2020-09-16       Impact factor: 4.566

9.  Vein of Marshall Ethanol Infusion: Feasibility, Pitfalls, and Complications in Over 700 Patients.

Authors:  Tsukasa Kamakura; Nicolas Derval; Josselin Duchateau; Arnaud Denis; Takashi Nakashima; Takamitsu Takagi; F Daniel Ramirez; Clémentine André; Philipp Krisai; Yosuke Nakatani; Romain Tixier; Rémi Chauvel; Ghassen Cheniti; Kengo Kusano; Hubert Cochet; Frédéric Sacher; Mélèze Hocini; Pierre Jaïs; Michel Haïssaguerre; Thomas Pambrun
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.